Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1. Kim J, Villar Z, Jobe O, Rerks-Ngarm S, et al. Virology 2024;597:110158.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim J, Villar Z, Jobe O, Rerks-Ngarm S, et al. Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1. Virology 2024;597:110158.
PMID: 38941746